Seed, Series A
$1.0M – $10.0M
$5.5B
9+ companies
11 partners
Investment Thesis
Versant focuses exclusively on creating and financing innovative biotechnology companies pushing the frontier of cell and gene therapy.
Meet the Team
Bijan Salehizadeh
Managing Partner
Industry Focus
Invests In
Portfolio Companies (9)
Other
Jasper Therapeutics
Revolutio
Versant Venture Capital VIII, L.P. (CIK 0001832242)
SEC Form D filing mentioning Versant Ventures
Versant Venture Capital IX, L.P. (CIK 0001947469)
SEC Form D filing mentioning Versant Ventures
Versant Venture Capital SPV I (SAB), L.P. (CIK 0002020185)
SEC Form D filing mentioning Versant Ventures
Versant Vantage II, L.P. (CIK 0001832235)
SEC Form D filing mentioning Versant Ventures
Versant Voyageurs II, L.P. (CIK 0001832243)
SEC Form D filing mentioning Versant Ventures
Versant Voyageurs III, L.P. (CIK 0001947466)
SEC Form D filing mentioning Versant Ventures
Versant Vantage III, L.P. (CIK 0001947467)
SEC Form D filing mentioning Versant Ventures
- •Raising at Seed, Series A? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare, Other — the sectors they actively back.
- •Size your ask to their typical $1.0M – $10.0M check.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Don Milder, Managing Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Versant Ventures is a match for your startup
Upload your pitch deck to see how well you match with Versant Ventures and 10,000+ other investors.
Is this your profile? Request a correction or removal